Senti Biosciences Holdings (SNTI) Receivables (2021 - 2026)
Senti Biosciences Holdings (SNTI) recorded Receivables of $600,000 in Q2 2026, down 91.7% from $7.19 million a year earlier.
Powered by 
Analysis
Senti Biosciences Holdings (SNTI) Receivables (2021 - 2026) Analysis & Trends
At the end of FY2025, Senti Biosciences Holdings reported Receivables of $1.6 million, down 11.6% from FY2024.
- Annual Receivables has a four-year compound annual growth rate of 34.8% (FY2021 to FY2025).
- Across earlier years, Receivables came in at $1.81 million in FY2024 (-89.8%), $17.7 million in FY2023, $626,000 in FY2022 (+29.6%) and $483,000 in FY2021.
- The Q2 2026 figure is the lowest quarterly Receivables since Q2 2023.
- On a year-over-year basis, Receivables rose in 1 of the last seven quarters, with an average decline of 33.8%.
- Peak year-over-year performance for Receivables in the last five years was growth of 200.4% in Q3 2025, against a decline of 94.0% in Q3 2024 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 19.05 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 13.82 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 12.56 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 9.64 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 15.68 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 10.23 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 5.06 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 12.49 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 2.13 Bn |
| 10 | Senti Biosciences Holdings | 9.65 Mn | 9.65 Mn | - | 600,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 600,000.00 |
| Dec 31, 2025 | 1.60 Mn |
| Sep 30, 2025 | 3.34 Mn |
| Jun 30, 2025 | 7.19 Mn |
| Mar 31, 2025 | 2.10 Mn |
| Dec 31, 2024 | 1.81 Mn |
| Sep 30, 2024 | 1.11 Mn |
| Jun 30, 2024 | 18.66 Mn |
| Mar 31, 2024 | 17.92 Mn |
| Dec 31, 2023 | 17.70 Mn |
| Sep 30, 2023 | 18.62 Mn |
| Jun 30, 2023 | 567,000.00 |
| Mar 31, 2023 | 791,000.00 |
| Dec 31, 2022 | 626,000.00 |
| Sep 30, 2022 | 846,000.00 |
| Jun 30, 2022 | 573,000.00 |
| Dec 31, 2021 | 483,000.00 |
API Access
Senti Biosciences Holdings Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=SNTI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "SNTI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=SNTI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();